Condition

Hematologic Cancer

ClinicalTrials.gov condition label

Clinical trials8

Recruiting4

Common interventions7

Lead sponsors shown8

Clinical trials

8 shown

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyNCT07039474 · 2026-09-08

The Florida ASCENT StudyNCT07042243 · 2025-12-05

Improving Comprehensive Care of Cancer PatientsNCT05323409 · 2022-04-01

Avera Cancer Sequencing and Analytics Protocol (ASAP)NCT05142033 · 2021-11-01

Precision Physical Exercise for Personalized Onco-Hematology.NCT07286539 · 2026-04-01

NOT_YET_RECRUITING

Physical Therapy in Patients Undergoing Allo-HSCT With cGVHDNCT06279585 · 2024-03-01

Symptom Management for YA Cancer SurvivorsNCT04035447 · 2020-01-22

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood SamplesNCT01792882 · 2013-02-01

Common interventions

18F-G1DRUG1 Behavioral Symptom Management for Young Adult Cancer SurvivorsBEHAVIORAL1 Home-based InterventionOTHER1 MyCarePulse and ASCENT PNBEHAVIORAL1 OPTIMISEBEHAVIORAL1 Physical therapyOTHER1 Supervised InterventionOTHER1

Leading sponsors

Avera McKennan Hospital & University Health Center1 Baylor College of Medicine1 Duke University1 Global BioClinical1 Peking University First Hospital1 University of Florida1 University of Salamanca1 University of Seville1

Trial status mix

RECRUITING4

COMPLETED1

NOT_YET_RECRUITING1

UNKNOWN1

WITHDRAWN1

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.